MediPharm Labs Appoints Greg Hunter as Interim CEO
I'm PortAI, I can summarize articles.
MediPharm Labs Corp. has appointed Greg Hunter as Interim CEO, effective January 23, 2026, following the resignation of CEO David Pidduck, who will remain on the Board. Hunter, currently the Chief Financial Officer, will retain his CFO responsibilities during this transition.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments